These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1755006)

  • 1. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
    Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human prostacyclin platelet receptors and platelet lipid composition.
    Modesti PA; Abbate R; Prisco D; Gensini GF
    J Lipid Mediat; 1990; 2(6):309-15. PubMed ID: 2133274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus.
    Akai T; Naka K; Okuda K; Takemura T; Fujii S
    Horm Metab Res; 1983 Nov; 15(11):523-6. PubMed ID: 6360841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets.
    Jakubowski JA; Utterback BG; Mais DE; Hardinger SA; Braish TF; Nevill CR; Fuchs PL
    Prostaglandins; 1994 Mar; 47(3):189-201. PubMed ID: 8016389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a novel circulating anti-prostacyclin receptor antibody.
    Kahn NN; Bauman WA; Sinha AK
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8779-82. PubMed ID: 9238054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man.
    Modesti PA; Fortini A; Poggesi L; Boddi M; Abbate R; Gensini GF
    Thromb Res; 1987 Dec; 48(6):663-9. PubMed ID: 2448896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age related changes of platelet prostacyclin receptors in humans.
    Modesti PA; Fortini A; Abbate R; Gensini GF
    Eur J Clin Invest; 1985 Aug; 15(4):204-8. PubMed ID: 2995049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
    Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
    Kahn N; Sinha A; Bauman W
    Clin Physiol; 2001 Jan; 21(1):60-6. PubMed ID: 11168298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet stimulation for prostacyclin production in aortic endothelial cell cultures: alteration in diabetes mellitus.
    Inoguchi T; Umeda F; Kunisaki M; Ishii H; Yamauchi T; Nawata H
    Horm Metab Res; 1991 Nov; 23(11):539-44. PubMed ID: 1816065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
    Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
    Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-stimulated thrombin and PDGF are normalized by insulin and Ca2+ channel blockers.
    Kahn NN
    Am J Physiol; 1999 May; 276(5):E856-62. PubMed ID: 10329979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The platelet rebound phenomenon during PGI2-infusion occurs at the receptor level.
    Steurer G; Fitscha P; Sinzinger H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):435-8. PubMed ID: 2465947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet prostacyclin binding in smokers.
    Jaschonek K; Weisenberger H; Tidow S; Daiss W; Renn W; Ostendorf P
    J Lab Clin Med; 1986 Aug; 108(2):88-95. PubMed ID: 3016128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.